Iowa Legislature Passes Bill Regulating E-cigarette Sales

Regulations by 2FIRSTS.ai

Apr.24.2024

Iowa Legislature Passes Bill Regulating E-cigarette Sales

Iowa legislators pass bill regulating e-cigarette sales, waiting for Governor Kim Reynolds' signature, impacting retailers and FDA regulations.

According to Kcci on April 23rd, the Iowa House of Representatives and Senate passed a bill last week that regulates the sale of e-cigarette products, which is now awaiting Governor Kim Reynolds' signature.

House Bill 2677 will ban retailers from selling e-cigarette products that are not registered with the state's approval. State Senator Chris Cournoyer stated that the new law will remove unsafe products from store shelves.

It also provides us with an enforcement mechanism, and gives them that list, so we can go in and know which updates they have, what can and cannot be sold in the store.

A dealer in the state said that the bill would make more than 99% of their products illegal. The company was already in a vulnerable position before the bill was introduced. Currently, all 23 e-cigarette products approved by the FDA must submit pre-market review applications by September 9, 2020. The dealer stated that they were one of the 25 million applications rejected by the FDA.

Currently, the governor of the state needs to sign the bill before mid-May. The bill will take effect 30 days after the end of the legislative session, which is on July 1st.

References:

[1] Bill tightening regulations on vape products awaiting governor's signature

Also Read:

[1] Iowa Joins "I-PLEDGE" Program: Preventing Tobacco and E-Cigarettes Sales to Minors

[2] Juul Settles with Iowa Over Underage Marketing

[3] Warnings Issued on Dangers of E-cigarettes in Iowa

#North America #United States #Legislation #E-cigarettes

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

Imperial Brands launches ZONE nicotine pouches in the UK, covering the core 9–12 mg strength segment

Imperial Brands has launched its ZONE nicotine pouches in the UK, targeting the mainstream 9–12 mg nicotine strength segment. The brand debuts with five flavours at a recommended retail price of £6.50 per can. Mint variants currently account for around 70% of UK nicotine pouch sales, while fruit flavours are growing rapidly. ZONE will be distributed primarily through independent retail channels.

Nov.18 by 2FIRSTS.ai

Product | Up to 100,000 Puffs and Over 2,000 Puffs per ml: MASKKING, MR FOG, HYPERBAR Roll Out Ultra High-Puff New Devices

In 2025, disposable vapes are shifting from a “puff count race” to a focus on user experience. While 30,000–50,000 puffs has become mainstream, brands like MASKKING, MR FOG, and HYPERBAR are still launching higher-capacity products in the 60,000–100,000 puff range. Models with disclosed tank sizes all exceed 2,000 puffs per mL and commonly feature adjustable wattage and enhanced interactive functions.

Nov.14 by 2FIRSTS.ai

Kazakhstan Denies Rumors of Easing Hookah and Vape Restrictions: Deputy Interior Minister Reaffirms “Zero Tolerance” for Vapes

Kazakhstan’s Deputy Interior Minister Sanzhar Adilov (Санжар Адилов) addressed social media rumors that the government may ease restrictions on hookahs and vapes. He confirmed that hookah regulations are under interagency review, but the strict ban on vapes remains unchanged and has recently been reinforced with criminal liability.